Insider Trading activities of Epicept Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Epicept Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Epicept Corp since year 2005. Table 2 shows the detailed insider transactions of Epicept Corp since 2005. The reporting company's ticker symbol is IMNP. The reporting company's CIK number is 1208261.
The total value of stock buying since 2005 is $1,979,477.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $7,418.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Epicept Corp (IMNP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-01 76,503 $14,229 0 $0 0 $0
2016-12 161,377 $30,016 0 $0 0 $0
2016-10 0 $0 0 $0 185,473 $7,418
2016-08 2,381,945 $1,006,250 0 $0 0 $0
2016-01 187,600 $124,396 0 $0 0 $0
2015-12 215,400 $167,050 0 $0 0 $0
2015-10 96,700 $124,641 0 $0 0 $0
2015-09 107,569 $157,151 0 $0 0 $0
2014-11 38,400 $96,000 0 $0 0 $0
2012-12 0 $0 0 $0 800,000 $0
2007-12 110,000 $154,513 0 $0 0 $0
2007-09 2,600 $4,332 0 $0 0 $0
2007-08 62,600 $100,899 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Epicept Corp insiders (IMNP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-01-04 Kazado Daniel Buy 76,503 .19 14,229
2016-12-16 Kazado Daniel Buy 161,377 .19 30,016
2016-10-06 Teper Daniel Gedeon (CEO) Option Ex 185,473 .04 7,418
2016-08-04 Luchi Monica E. (EVP & CMO) Buy 777,778 .45 350,000
2016-08-04 Kazado Daniel Buy 666,667 .45 300,000
2016-08-04 Teper Daniel Gedeon (CEO) Buy 937,500 .38 356,250
2016-01-26 Teper Daniel Gedeon (CEO) Buy 42,000 .59 24,822
2016-01-19 Teper Daniel Gedeon (CEO) Buy 44,200 .57 25,017
2016-01-12 Teper Daniel Gedeon (CEO) Buy 39,400 .62 24,585
2016-01-05 Teper Daniel Gedeon (CEO) Buy 62,000 .81 49,972
2015-12-07 Kazado Daniel Buy 150,000 .78 117,150
2015-12-07 Teper Daniel Gedeon (CEO) Buy 65,400 .76 49,900
2015-10-26 Teper Daniel Gedeon (CEO) Buy 18,400 1.36 25,005
2015-10-19 Teper Daniel Gedeon (CEO) Buy 18,600 1.34 24,998
2015-10-12 Teper Daniel Gedeon (CEO) Buy 19,000 1.30 24,700
2015-10-05 Teper Daniel Gedeon (CEO) Buy 40,700 1.23 49,938
2015-09-14 Kazado Daniel Buy 50,000 1.47 73,500
2015-09-14 Azria Rene Pierre Buy 50,000 1.48 73,850
2015-09-01 Teper Daniel Gedeon (CEO) Buy 7,569 1.29 9,801
2014-11-26 Kazado Daniel Buy 8,000 2.50 20,000
2014-11-26 Berdugo Gad Buy 8,000 2.50 20,000
2014-11-26 Durrant Cameron Buy 4,000 2.50 10,000
2014-11-26 Stancic Ana Buy 8,000 2.50 20,000
2014-11-26 Sidransky David Buy 10,400 2.50 26,000
2012-12-27 Allard Stephane (Chief Medical Officer) Option Ex 350,000 .00 0
2012-12-27 Cook Robert W. (Interim Chief Exec. Officer) Option Ex 450,000 .00 0
2007-12-13 Talley John V (President, CEO & Director) Buy 15,000 1.40 21,000
2007-12-13 Cook Robert W (CFO-SVP, Finance & Admin.) Buy 5,000 1.35 6,750
2007-12-13 Savage Robert G (Director) Buy 30,000 1.38 41,340
2007-12-12 Wiedemann Oliver (Managing Director-See Remarks) Buy 5,000 1.40 7,000
2007-12-12 Allard Stephane (Chief Medical Officer) Buy 11,800 1.42 16,697
2007-12-12 Bhagwat Dileep (SVP-Pharmaceutical Development) Buy 10,000 1.43 14,250
2007-12-11 Allard Stephane (Chief Medical Officer) Buy 33,200 1.43 47,476
2007-09-13 Allard Stephane (Chief Medical Officer) Buy 600 1.62 972
2007-09-04 Bedard John F (Director) Buy 2,000 1.68 3,360
2007-08-30 Cook Robert W (CFO-SVP, Finance & Admin.) Buy 1,803 1.69 3,047
2007-08-29 Cook Robert W (CFO-SVP, Finance & Admin.) Buy 8,197 1.66 13,607
2007-08-28 Talley John V (President, CEO & Director) Buy 10,000 1.65 16,450
2007-08-24 Bhagwat Dileep (SVP-Pharmaceutical Development) Buy 1,500 1.60 2,400
2007-08-23 Bhagwat Dileep (SVP-Pharmaceutical Development) Buy 1,000 1.61 1,610
2007-08-21 Savage Robert G (Director) Buy 28,600 1.60 45,645
2007-08-20 Savage Robert G (Director) Buy 7,500 1.58 11,820
2007-08-17 Savage Robert G (Director) Buy 4,000 1.58 6,320

Insider trading activities including stock purchases, stock sales, and option exercises of IMNP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Epicept Corp (symbol IMNP, CIK number 1208261) see the Securities and Exchange Commission (SEC) website.